- Sharing the role of technology and partnerships in the design & recruitment of studies.
- Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
- Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Reproductive Health
Drug Development
Med Device
- Demystifying product-market fit in the context of digital health, where clinical need, usability, and reimbursement must align.
- Identifying key indicators—user adoption, engagement, and outcomes—that show readiness to scale.
- Strategies for translating validated need into scalable, sustainable digital health solutions.
Innovation and Investment
- Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
- Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
- Sharing advancements to educate clinical trial patients about menopause.
Menopause and Longevity
Drug Development
Johan van Hylckama
CSO
Freya Biosciences
Understanding the payer mindset, what is valuable in women’s healthcare innovation.
Defining clinical outcomes, cost containment, and population impact.
Determining Evidence for Adoption & Reimbursement, what is ‘gold standard data’.
Case examples of evidence that moved the needle, RWE, and how to avoid common mistakes
Reproductive Health
Healthcare Costs and Outcomes
Karolina Löfqvist
CEO & Co-Founder
Hormona
Omid Toloui
Adjunct Professor, UCLA Anderson School of Management
Former VP of Innovation, Elevance Health
Jennifer Li
Health Ecosystem & Partnerships
Samsung
Exploring the current landscape of screening services in women’s cancers and market opportunities to address unmet need.
Sharing how AI, technology, and genetic testing can address gaps in access.
How providers and patients can be equipped with tools for early detection and cancer prevention.
Oncology
Digital Health
Heidi Glasser
Director of Corporate Affairs
Medicines360
Kristine Cecchetti
Senior Product Manager, Women’s Health Strategy
Evernorth
Mary Dinnean
Director, Enterprise Strategic Initiatives
Elevance Health
Rachel Brem
Chief Medical Director
Brem Foundation
- How the demand for menopause-focused functional foods, probiotics, and supplements is shaping new business opportunities.
- Sharing insights into how nutrition and food as medicine links bone, heart, and brain health in menopause and the opportunity to address these health outcomes through wellness.
- Expanding access to menopause nutrition solutions through pharmacies, e-commerce, consumer wellness, and employer plans.
Menopause and Longevity
Nutrition and Food as Medicine
Jaqueline Oliveira-Cella
Founder
wellBe Consulting
Christine Bishara
Integrative Medical Doctor
The Gut Revolution
Margarita Ochoa-Maya
Internal Medicine Endocrinologist & Senior Medical Director
Amgen
Pamela Basada-Lombana
Vice President, Research & Development
Helaina
Laura Katz
CEO
Helaina
Miller Morris
CEO
Comma